Marketing Cancer Drugs To Physicians Increases Prescribing Without Improving Mortality
Abstract of a paper on National Bureau of Economic Research: Physicians commonly receive marketing-related transfers from drug firms. We examine the impact of these relationships on the prescribing of physician-administered cancer drugs in Medicare. We find that prescribing of the associated drug inc … ⌘ Read more